$2.99
0.70% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US09061H3075
Symbol
BMRA

Biomerica, Inc. Stock price

$2.99
-0.04 1.32% 1M
-2.58 46.30% 6M
+0.59 24.54% YTD
+0.51 20.53% 1Y
-21.71 87.90% 3Y
-69.97 95.90% 5Y
-4.61 60.66% 10Y
-1.01 25.25% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
-0.02 0.70%

Key metrics

Basic
Market capitalization
$7.7m
Enterprise Value
$4.6m
Net debt
positive
Cash
$3.1m
Shares outstanding
2.6m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.3 | -
EV/Sales
0.8 | -
EV/FCF
negative
P/B
1.4
Financial Health
Equity Ratio
71.2%
Return on Equity
-90.7%
ROCE
-89.0%
ROIC
-140.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$5.7m | -
EBITDA
$-4.5m | -
EBIT
$-5.1m | -
Net Income
$-4.9m | -
Free Cash Flow
$-4.3m
Growth (TTM | estimate)
Revenue
5.2% | -
EBITDA
32.1% | -
EBIT
23.6% | -
Net Income
23.6% | -
Free Cash Flow
20.4%
Margin (TTM | estimate)
Gross
13.5%
EBITDA
-79.0% | -
EBIT
-89.8%
Net
-85.4% | -
Free Cash Flow
-75.5%
More
EPS
$-2.0
FCF per Share
$-1.7
Short interest
2.8%
Employees
64
Rev per Employee
$80.0k
Show more

Is Biomerica, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Biomerica, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Biomerica, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Biomerica, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Feb '25
+/-
%
5.68 5.68
5% 5%
100%
- Direct Costs 4.91 4.91
3% 3%
86%
0.77 0.77
24% 24%
14%
- Selling and Administrative Expenses 4.83 4.83
15% 15%
85%
- Research and Development Expense 1.04 1.04
35% 35%
18%
-4.49 -4.49
32% 32%
-79%
- Depreciation and Amortization 0.61 0.61
771% 771%
11%
EBIT (Operating Income) EBIT -5.10 -5.10
24% 24%
-90%
Net Profit -4.85 -4.85
24% 24%
-85%

In millions USD.

Don't miss a Thing! We will send you all news about Biomerica, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Biomerica, Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company focused on innovative gastroenterology diagnostics, today announced that the American Medical Association CPT editorial panel has issued a Current Procedural Terminology (CPT®) code in the Proprietary Laboratory Analysis (PLA) code category for the Company's inFoods® IBS test.
Neutral
GlobeNewsWire
about 2 months ago
IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, today announced the appointment of Scott Madel as Chief Commercial Officer.
Neutral
GlobeNewsWire
2 months ago
Mr. Chin brings over 20 years of financial experience across public and private healthcare organizations Mr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financing Mr.
More Biomerica, Inc. News

Company Profile

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. It focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, United States, Asia, South America, Middle East, and Other Foreign. The company was founded in September 1971 and is headquartered in Irvine, CA.

Head office United States
CEO Zackary Irani
Employees 64
Founded 1971
Website biomerica.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today